Raw Materials for Cell & Gene Therapy: Getting it Right from the Start

CELL AND GENE THERAPY INSIGHTS

February 2017

Raw Materials for Cell & Gene Therapy: Getting it Right from the Start

Download PDF

Innovator Insight

Raw materials for cell & gene therapy: exploring regulatory and supply issues

Raw materials for cell & gene therapy: exploring regulatory and supply issues

Strategic & practical considerations in raw material selection & sourcing for cell therapies

Strategic & practical considerations in raw material selection & sourcing for cell therapies

David Wellis, Robert Tressler

Interview

Optimizing the Cell Collection Network to Support the Commercialization of Cell & Gene Therapies

Optimizing the Cell Collection Network to Support the Commercialization of Cell & Gene Therapies

Amy Hines, Kimberly Kasow, Sandra Hoffmann

Perspectives on the use of ancillary materials for cell and gene therapies

Perspectives on the use of ancillary materials for cell and gene therapies

Shirley Bartido

Understanding the Role of Critical Quality Attributes along the Commercialization Pathway

Understanding the Role of Critical Quality Attributes along the Commercialization Pathway

Impact of raw & starting materials on the manufacture and regulation of gene & cell therapies

Impact of raw & starting materials on the manufacture and regulation of gene & cell therapies

Richard Dennett, Valerie Pimpaneau, Francois Gianelli

Commercial considerations for raw materials in the cell and gene therapy industry

Commercial considerations for raw materials in the cell and gene therapy industry

Scope and challenges of managing particulates in cell therapy manufacturing

Scope and challenges of managing particulates in cell therapy manufacturing

Webinars

“One Word: Plastics” – The Role of Material Science in Cell Therapy Manufacturing

“One Word: Plastics” – The Role of Material Science in Cell Therapy Manufacturing

Natasha Boghosian, Katie Campbell